J. Goldman & Co’s Health Assurance Acquisition Corp. Class A Common Stock HAAC Stock Holding History

J. Goldman & Co’s Portfolio HAAC Stock Details HAAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-600,595	Closed	-$6M	–	551
2022 Q3	$6M	Hold	600,595	–	–	0.29%	105
2022 Q2	$5.93M	Hold	600,595	–	–	0.29%	92
2022 Q1	$5.92M	Hold	600,595	–	–	0.27%	108
2021 Q4	$5.87M	Buy	600,595 +408,741	+213%	+$4.01M	0.32%	90
2021 Q3	$1.88M	Hold	191,854	–	–	0.09%	193
2021 Q2	$1.92M	Buy	191,854 +41,854	+28%	+$427K	0.07%	228
2021 Q1	$1.53M	Buy	+150,000	New	+$1.78M	0.05%	261

Other funds holding HAAC

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

J. Goldman & Co's HAAC Position: Q4 2022 in Review

J. Goldman & Co sold out of Health Assurance Acquisition Corp. Class A Common Stock (HAAC) in Q4 2022, closing a stake of 600,595 shares — an estimated $6M sold.

J. Goldman & Co first reported a position in HAAC in Q1 2021 and held it in 7 quarters. The position peaked at $6M in Q3 2022. 1 fund tracked by Wall St. Rank holds HAAC as of Q4 2022.

J. Goldman & Co reported no remaining Health Assurance Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
J. Goldman & Co sold 600,595 Health Assurance Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $6M.
J. Goldman & Co first reported a position in Health Assurance Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 7 quarters.
J. Goldman & Co's Health Assurance Acquisition Corp. Class A Common Stock position peaked at $6M in Q3 2022.
1 fund tracked by Wall St. Rank held Health Assurance Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on J. Goldman & Co's 13F filing for Q4 2022, filed 14 Feb 2023.